{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:24:52Z","timestamp":1760783092454,"version":"build-2065373602"},"reference-count":25,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p>Albright hereditary osteodystrophy (AHO) is an autosomal dominant disorder characterised by the presence of brachymetaphalangism, short stature, obesity, and mental retardation. Variable biochemical changes many represent either pseudohypoparathyroidism (PHP) owing to resistance to parathormone (PTH) or pseudopseudohypoparathyroidism (PPHP) with no hormone resistance. In most cases of AHO, reduced levels of Gs alpha have been found and a number of deactivating mutations in the gene for Gs alpha located on chromosome 20q13 have been described. Recently a number of people with an AHO-like phenotype have been reported in whom a deletion of chromosomal region 2q37 has been found in the absence of biochemical abnormalities or a reduction in Gs alpha activity. We present a further female patient with a cytogenetically visible deletion of 2q37, an AHO-like phenotype, and unusual biochemistry suggesting moderate PTH resistance. The vasoactive intestinal peptide receptor (RDCI) has recently been mapped to 2q37 and we propose that this is a candidate gene, hemizygosity of which affects signal transduction and leads to the AHO-like phenotype found in patients with 2q37 deletions.<\/jats:p>","DOI":"10.1136\/jmg.34.4.287","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:37:21Z","timestamp":1226331441000},"page":"287-290","source":"Crossref","is-referenced-by-count":27,"title":["RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37."],"prefix":"10.1136","volume":"34","author":[{"given":"M M","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B A","family":"Leatherdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Hatchwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1997,4,1]]},"reference":[{"key":"ref_1","first-page":"922","article-title":"Pseudohypoparathyroidism: an example of \"Seabright-Bantam syndrome\"","volume":"30","author":"Albright, F.; Burnett, C.H.; Parson, W.","year":"1942","unstructured":"Albright F, Burnett CH, Parson W. Pseudohypoparathyroidism: an example of \"Seabright-Bantam syndrome\". Endocrinology 1942;30:922-32.","journal-title":"Endocrinology"},{"key":"ref_2","first-page":"337","volume":"65","author":"Albright, F.; Forbes, A.P.; Henneman, P.H.","year":"1952","unstructured":"Albright F, Forbes AP, Henneman PH. Pseudopseudohypoparathyroidism. Trans Assoc Am Physicians 1952;65:337-50.","journal-title":"Pseudopseudohypoparathyroidism. Trans Assoc Am Physicians"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.1320580102","article-title":"Albright hereditary osteodystrophy and del(2)(q37.3) in four unrelated individuals","volume":"58","author":"Phelan, M.C.; Curtis Rogers, R.; Clarkson, K.B.","year":"1995","unstructured":"Phelan MC, Curtis Rogers R, Clarkson KB, et al. Albright hereditary osteodystrophy and del(2)(q37.3) in four unrelated individuals. Am J Med Genet 1995;58: 1-7.","journal-title":"Am J Med Genet"},{"key":"ref_4","first-page":"400","article-title":"Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localised to 2q37","volume":"56","author":"Wilson, L.C.; Leverton, K.; Oude Luttikhuis, M.E.M.","year":"1995","unstructured":"Wilson LC, Leverton K, Oude Luttikhuis MEM, et al. Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localised to 2q37. Am J Hum Genet 1995;56:400-7.","journal-title":"Am J Hum Genet"},{"key":"ref_5","first-page":"1571","article-title":"Microdeletion in chromosome 2qter in two unrelated children with characteristic facies and mental retardation","volume":"53","author":"Haag, M.; Gilfillan, T.; Berry, R.","year":"1993","unstructured":"Haag M, Gilfillan T, Berry R, et al. Microdeletion in chromosome 2qter in two unrelated children with characteristic facies and mental retardation. Am J Hum Genet 1993;53:A1571.","journal-title":"Am J Hum Genet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-4608(83)90044-4","article-title":"Fluorodeoxyuridine synchronization of bone marrow cultures","volume":"8","author":"Weber, L.M.; Garson, O.M.","year":"1983","unstructured":"Weber LM, Garson OM. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet 1983; 8:123-32.","journal-title":"Cancer Genet Cytogenet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0888-7543(92)90133-D","article-title":"Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms","volume":"13","author":"Hudson, T.J.; Engelstein, M.; Lee, M.K.","year":"1992","unstructured":"Hudson TJ, Engelstein M, Lee MK, et al. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 1992;13: 622-9.","journal-title":"Genomics"},{"key":"ref_8","first-page":"355","article-title":"Clinical studies and applications or cyclic nucleotides","volume-title":"Advances in cyclic nucleotide research","author":"Murad, F.","year":"1973","unstructured":"Murad F. Clinical studies and applications or cyclic nucleotides. In: Robinson GA, ed. Advances in cyclic nucleotide research. New York: Raven Press, 1973:355."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(76)90152-5","article-title":"A simplified assessment of response to PTH in hypoparathyroid patients","volume":"i:","author":"Tomlinson, S.; Hendy, G.N.; O'Riordan, J.L.H.","year":"1976","unstructured":"Tomlinson S, Hendy GN, O'Riordan JLH. A simplified assessment of response to PTH in hypoparathyroid patients. Lancet 1976;i:62-4.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jmg.31.10.779","article-title":"Albright hereditary osteodystrophy","volume":"31","author":"Wilson, L.C.; Trembath, R.C.","year":"1994","unstructured":"Wilson LC, Trembath RC. Albright hereditary osteodystrophy. _Med Genet 1994;31:779-84.","journal-title":"_Med Genet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajmg.1320530412","article-title":"the long arm of chromosome 2: two new cases","volume":"53","author":"Fisher, A.M.; Ellis, K.H.; Barber, J.C.K.","year":"1995","unstructured":"Fisher AM, Ellis KH, Barber JCK, et al. Small terminal deletions of the long arm of chromosome 2: two new cases. Am JMed Genet 1995;53:366-9.","journal-title":"Am JMed Genet"},{"key":"ref_12","first-page":"32","article-title":"A patient with a minute terminal deletion of chromosome 2 long arm","volume":"47","author":"Lamb, A.N.; Roche, M.; Kirkman, H.N.; Rao, K.W.; Aylsworth, A.S.","year":"1990","unstructured":"Lamb AN, Roche M, Kirkman HN, Rao KW, Aylsworth AS. A patient with a minute terminal deletion of chromosome 2 long arm. Am J Hum Genet 1990;47:A32.","journal-title":"Am J Hum Genet"},{"key":"ref_13","first-page":"153","volume":"51","author":"Stratton, R.F.; Tolworthy, J.A.; Young, R.S.","year":"1994","unstructured":"Stratton RF, Tolworthy JA, Young RS. Deletion (2)(q37). Am JMed Genet 1994;51:153-5.","journal-title":"Deletion"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ajmg.1320440424","article-title":"the long arm of chromosome 2 in a mildly affected boy","volume":"44","author":"Lin, S.P.; Petty, E.M.; Gibson, L.H.; Inserra, J.A.; Seashore, M.R.; terminal deletion of, Yang-Feng T.L.Smallest","year":"1992","unstructured":"Lin SP, Petty EM, Gibson LH, Inserra JA, Seashore MR, Yang-Feng TL. Smallest terminal deletion of the long arm of chromosome 2 in a mildly affected boy. Am J Med Genet 1992;44:500-2.","journal-title":"Am J Med Genet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1399-0004.1995.tb04073.x","article-title":"Clinical phenotype associated with terminal 2q37 deletion","volume":"48","author":"Dewald, C.B.; Christensen, G.; Lopez, E.; Higgins, J.; Pierpont, M.E.","year":"1995","unstructured":"Dewald CB, Christensen G, Lopez E, Higgins J, Pierpont ME. Clinical phenotype associated with terminal 2q37 deletion. Clin Genet 1995;48:134-9.","journal-title":"Clin Genet"},{"key":"ref_16","first-page":"301","article-title":"An infant with karyotype 46, XX, del(2)(q37) and severe congenital malformations","volume":"51","author":"Coldwell, J.G.; Gucsavas, M.; Say, B.; Carpenter, N.J.; Chapmen, H.A.","year":"1992","unstructured":"Coldwell JG, Gucsavas M, Say B, Carpenter NJ, Chapmen HA. An infant with karyotype 46,XX,del(2)(q37) and severe congenital malformations. Am 7 Hum Genet 1992;51:A301.","journal-title":"Am 7 Hum Genet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.1320490410","article-title":"Terminal deletion of the long arm of chromosome 2 in a premature infant with karyotype: 46, XY, del(2) (q37)","volume":"49","author":"Wang, T.H.; Johnston, K.; Hsieh, C.L.; Dennery, P.A.","year":"1994","unstructured":"Wang TH, Johnston K, Hsieh CL, Dennery PA. Terminal deletion of the long arm of chromosome 2 in a premature infant with karyotype: 46,XY,del(2) (q37). Am J Med Genet 1994;49:399-401.","journal-title":"Am J Med Genet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.1320320315","article-title":"Terminal deletion of the long arm of chromosome 2 in a mildly dysmorphic hypotonic infant with karyotype 46, XY, del(2)(q37)","volume":"32","author":"Gorski, J.L.; Cox, B.A.; Kyine, M.; Uhlmann, W.; Glover, T.W.","year":"1989","unstructured":"Gorski JL, Cox BA, Kyine M, Uhlmann W, Glover TW. Terminal deletion of the long arm of chromosome 2 in a mildly dysmorphic hypotonic infant with karyotype 46,XY,del(2)(q37). Am J Med Genet 1989;32:350-2.","journal-title":"Am J Med Genet"},{"key":"ref_19","first-page":"310","article-title":"Deletion of 2q37 - a new syndrome?","volume":"51","author":"Stein, C.K.; Del Signore, C.; Bellinger, M.; Bryke, C.R.","year":"1992","unstructured":"Stein CK, Del Signore C, Bellinger M, Bryke CR. Deletion of 2q37 - a new syndrome? AmJf Hum Genet 1992;51: A310.","journal-title":"AmJf Hum Genet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.1320110104","article-title":"Albrights hereditary osteodystrophy: a review","volume":"11","author":"Fitch, N.","year":"1982","unstructured":"Fitch N. Albrights hereditary osteodystrophy: a review. Am J Med Genet 1982;11:11-29.","journal-title":"Am J Med Genet"},{"article-title":"Parathyroid hormone resistence","author":"Cole, D.","key":"ref_21","unstructured":"Cole D. Parathyroid hormone resistence. In: Buyse ML, ed. Birth defects encyclopedia. New York: Blackwell Scientific Publications, 1990:1368."},{"key":"ref_22","article-title":"Albright hereditary osteodystrophy syndrome. In: Recognisable patterns of human malformation. Genetic, embryologic and clinical aspects","author":"Smith, D.W.","unstructured":"Smith DW. Albright hereditary osteodystrophy syndrome. In: Recognisable patterns of human malformation. Genetic, embryologic and clinical aspects. 3rd ed. London: W B Saunders, 1982:324.","edition":"3rd ed"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0888-7543(91)90125-X","article-title":"Chromosomal mapping of Al and A2 adenosive receptors, VIP receptor, and a new subtype of serotonin receptor","volume":"11","author":"Libert, F.; Passage, E.; Parmentier, M.; Simons, K.J.; Vassart, G.; Mattei, M.G.","year":"1991","unstructured":"Libert F, Passage E, Parmentier M, Simons KJ, Vassart G, Mattei MG. Chromosomal mapping of Al and A2 adenosive receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics 1991;11:225-7.","journal-title":"Genomics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"\"1233","DOI":"10.1210\/endo-112-4-1233","article-title":"Vasoactive intestinal peptide stimulates bone resorption via a cyclicadenosine 3'5'-monophosphate-dependent mechanism","volume":"112","author":"Hohmann, E.L.; Levine, L.; Tashjian, A.H.","year":"1983","unstructured":"Hohmann EL, Levine L, Tashjian AH. Vasoactive intestinal peptide stimulates bone resorption via a cyclicadenosine 3'5'-monophosphate-dependent mechanism. Endocrinology 1983;112: 1233-9 27 Leavey SF, Holloway H, Courtney MG, et al. Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and theraputic modalities. Irish7 Med Sci 1995; 164:37-9.","journal-title":"Endocrinology; Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and theraputic modalities"},{"key":"ref_25","first-page":"555","article-title":"Chromosomal assignment of human VIP\/PHM-27 gene to 6q26-q27 region by spot blot hybridization and in situ hybridization","volume":"17","author":"Gotoh, E.; Yamagami, T.; Yamamoto, H.; Okamoto, H.","year":"1988","unstructured":"Gotoh E, Yamagami T, Yamamoto H, Okamoto H. Chromosomal assignment of human VIP\/PHM-27 gene to 6q26-q27 region by spot blot hybridization and in situ hybridization. BiochemInt 1988;17:555-62.","journal-title":"BiochemInt"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.34.4.287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:22:36Z","timestamp":1760721756000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.34.4.287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1997,4,1]]},"published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1136\/jmg.34.4.287"],"URL":"https:\/\/doi.org\/10.1136\/jmg.34.4.287","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"type":"print","value":"0022-2593"},{"type":"electronic","value":"1468-6244"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}